Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 20/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27410695 | 0.80 | PDPK1 (0.47) | — | |
| SCHEMBL1019783 | 0.80 | GHSR (0.43) | HRH3 | |
| SCHEMBL1788202 | 0.77 | KCNB1 (0.43) | HRH3CYP2D6 | |
| SCHEMBL5459934 | 0.77 | HRH3 (0.53) | HRH3CYP2D6 | |
| SCHEMBL12748410 | 0.75 | HRH3 (0.39) | HRH3CYP2D6 | |
| SCHEMBL5464287 | 0.74 | HRH3 (0.50) | HRH3CYP2D6 | |
| SCHEMBL1790533 | 0.70 | ROCK2 (0.48) | HRH3HRH1 | |
| SCHEMBL3241945 | 0.70 | PDPK1 (0.42) | — | |
| SCHEMBL5453321 | 0.69 | HRH3 (0.48) | HRH3CYP2D6 | |
| SCHEMBL2115820 | 0.69 | GPR119 (0.57) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185089-A1 | Benzazepine derivatives for the treatment of neurological and psychiatric disorders | GLAXO GROUP LIMITED (GB) | 2007-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185089-A1 | Benzazepine derivatives for the treatment of neurological and psychiatric disorders | CNR2, GRIN2C, GRIN2B | HRH3 38/4885CYP2D6 425/4885HRH1 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.